Previously, however, evidence was presented that loss-of-function variants in ANGPTL3 are associated with a decreased risk of CAD.47,48 As the common variants adjacent to ANGPTL3 only modestly impacted plasma lipids, it could be argued that they do not accurately reflect the effects of more profound ANGPTL3 inactivation. Here, ANGPTL3 is linked to coronary artery disorder.